Africa & Middle East

Leishmaniasis is endemic in 80 countries, with an estimated 50,000 to 90,000 new cases reported annually, although WHO estimates that only 25% to 45% of infections are officially documented.

Under the proposed PPP structure, the Egyptian-Turkish consortium will oversee the project’s construction and non-medical operations.

The partnership combines Africa CDC’s continental leadership in health security with PSI’s experience in working with governments, communities and partners to design and scale people-centred healthcare solutions.

Africa CDC developed the resource through its Hepatitis B Group of Experts, in collaboration with the Centre for Operational Research on Hepatitis B, HEPSANET and the Society for the Study of Liver Disease in Africa.

Kalyan brings nearly 30 years of experience in the pharmaceutical and healthcare industries, including 18 years with Novo Nordisk.

The new facility will manufacture rapid diagnostic tests used in several areas of healthcare, including the detection of infectious diseases and epidemics, drug screening and the identification of cancer biomarkers.

The milestone also makes Qatar the third country worldwide to administer Itvisma and marks a significant step in the country’s precision medicine and rare disease care efforts.

The hospital has introduced the MONARCH™ platform, which allows physicians to navigate a flexible endoscope deep into the lungs with greater stability, control and precision.

During this period, manufacturers and importers will implement authentication and traceability for locally manufactured and imported HPTs through batch-level traceability using batch numbers declared to the PPB.

The network plans to scale diabetes care using a “clinic within a clinic” approach, enabling patients to access integrated and convenient services for chronic disease management.